Universal-Beteiligungs- und Servicegesellschaft’s Pacira BioSciences PCRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56M	Buy	140,434 +60,417	+76%	+$1.43M	0.01%	1065
2026 Q1	$1.81M	Buy	80,017 +10,920	+16%	+$243K	﹤0.01%	1283
2025 Q4	$1.79M	Buy	69,097 +54,079	+360%	+$1.29M	﹤0.01%	1290
2025 Q3	$387K	Sell	15,018 -2,624	-15%	-$64.5K	﹤0.01%	1825
2025 Q2	$422K	Buy	17,642 +1,856	+12%	+$46.8K	﹤0.01%	1727
2025 Q1	$392K	Buy	+15,786	New	+$378K	﹤0.01%	1703

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's PCRX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Pacira BioSciences (PCRX) stake by 76% in Q2 2026, buying an estimated $1.43M and bringing the position to 140,434 shares worth $3.56M. The position accounts for 0.01% of the portfolio, ranked #1065.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PCRX in Q1 2025 and has held it in 6 quarters since. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 140,434 shares of Pacira BioSciences worth $3.56M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft bought 60,417 Pacira BioSciences shares in Q2 2026, an estimated $1.43M.
Pacira BioSciences made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1065 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Pacira BioSciences in Q1 2025 and has held it in 6 quarters since.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.